Pharmacokinetics

Ophthalmology. 2009 Jan;116(1):168-9; author reply 169-70. doi: 10.1016/j.ophtha.2008.09.016.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Angiogenesis Inhibitors / pharmacokinetics*
  • Animals
  • Antibodies, Monoclonal / pharmacokinetics*
  • Antibodies, Monoclonal, Humanized
  • Aqueous Humor / metabolism*
  • Bevacizumab
  • Biological Availability
  • Half-Life
  • Models, Biological
  • Rabbits
  • Ranibizumab
  • Tissue Distribution
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Vitreous Body / metabolism*

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Vascular Endothelial Growth Factor A
  • Bevacizumab
  • Ranibizumab